medac passes eco-audit and receives award for environmental management medac Gesellschaft für klinische Spezialpräparate mbH is innovative, successful, sustainable and environment-friendly. The pharmaceutical company has proven that economic prosperity and environmental responsibility are not necessarily a contradiction. To achieve perfect conditions for this objective, medac subjected itself to an auditing procedure according to EMAS and […]
Benefits for psoriasis practices: New phase III data shows subcutaneous methotrexate’s favorable long-term efficacy and safety profile. Medac hosted a satellite symposium at the EADV conference 2016 in Vienna with the title METOP study – evaluation of subcutaneous methotrexate for psoriasis patients. Satellite symposium took place on Friday 30th of September, 2016 at Hall L3, floor […]
Medac hosts a Satellite symposium at the EULAR conference 2016 in London, with the title Best practice and future perspective of subcutaneous methotrexate. This will take place on Thursday the 9th of June 2016 at 8.15 am – 9.45, Room Capital Suite 2/4. EULAR invitation medac press release EULAR 2016 More information about the congress
Taloudellisten tietojen julkistaminen – medac GmbH sivuliike Suomessa 2015 Taloudellisten tietojen julkistaminen – medac GmbH sivuliike Suomessa 2016 Taloudellisten tietojen julkistaminen – medac GmbH sivuliike Suomessa 2017 Taloudellisten tietojen julkistaminen – medac GmbH sivuliike Suomessa 2018 Taloudellisten tietojen julkistaminen medac GmbH sivuliike Suomessa 2019 Muistio julkistamisessa kaytetyista menetelmista 2019
Press Release – medac passes eco-audit
/in kategorioimaton /by Admin medacmedac passes eco-audit and receives award for environmental management medac Gesellschaft für klinische Spezialpräparate mbH is innovative, successful, sustainable and environment-friendly. The pharmaceutical company has proven that economic prosperity and environmental responsibility are not necessarily a contradiction. To achieve perfect conditions for this objective, medac subjected itself to an auditing procedure according to EMAS and […]
EADV 2016 – METOP study in medac satellite symposium
/in kategorioimaton /by Carita KoskinenBenefits for psoriasis practices: New phase III data shows subcutaneous methotrexate’s favorable long-term efficacy and safety profile. Medac hosted a satellite symposium at the EADV conference 2016 in Vienna with the title METOP study – evaluation of subcutaneous methotrexate for psoriasis patients. Satellite symposium took place on Friday 30th of September, 2016 at Hall L3, floor […]
EULAR 2016 – medac satellite symposium
/in kategorioimaton /by Admin medacMedac hosts a Satellite symposium at the EULAR conference 2016 in London, with the title Best practice and future perspective of subcutaneous methotrexate. This will take place on Thursday the 9th of June 2016 at 8.15 am – 9.45, Room Capital Suite 2/4. EULAR invitation medac press release EULAR 2016 More information about the congress
Yhteistyö terveydenhuollon ammattilaisten kanssa
/in kategorioimaton /by Carita KoskinenTaloudellisten tietojen julkistaminen – medac GmbH sivuliike Suomessa 2015 Taloudellisten tietojen julkistaminen – medac GmbH sivuliike Suomessa 2016 Taloudellisten tietojen julkistaminen – medac GmbH sivuliike Suomessa 2017 Taloudellisten tietojen julkistaminen – medac GmbH sivuliike Suomessa 2018 Taloudellisten tietojen julkistaminen medac GmbH sivuliike Suomessa 2019 Muistio julkistamisessa kaytetyista menetelmista 2019